Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.
Part of SAFER@WORK program; publishes method for early detection of asymptomatic SARS-CoV-2 virus spreaders, that does not require human PCR clinical testing.